Metabolic associated fatty liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Chinese citizens aged = 18 and = 60. ? Meets MAFLD diagnostic criteria: In adults with hepatic steatosis (detected either by imaging techniques, blood biomarkers/scores, or liver histology), these three groups are classified as MAFLD, namely overweight/obesity (BMI = 23 kg/m2), type 2 diabetes (T2DM) or metabolic disorder. The presence of at least two of the following metabolic risk abnormalities: • Waist circumference =90/80 cm in men and women • Blood pressure =130/85 mmHg or specific drug treatment • Plasma triglycerides =150 mg/dL (=1.70 mmol/L) or specific drug treatment • Plasma HDL-cholesterol 2 mg/L ? The patient agrees and voluntarily joins this study and signs an informed consent form. ? The patient has completed MR-PDFF examination according to clinical needs, and the examination is within 1 week of enrollment time.
Exclusion criteria
Exclusion criteria: ? Pregnant. ? Patients undergoing systemic chemotherapy or biological therapy, or patients after TACE surgery; Patients with tumors in the liver lobe segments to be sampled. ? The course of diabetes patients is more than 2 years or has a history of kidney disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ultrasound Attenuation;Area under ROC curve; | — |
Secondary
| Measure | Time frame |
|---|---|
| HepatoRenal Index;Texture Index; | — |
Countries
China
Contacts
The Third Affiliated Hospital of Sun Yat-Sen University